David Gao, CEO of Beijing Med-Pharm, said: “We believe Rongheng’s established, tier-one distribution network will bolster our national presence to include Shanghai, one of China’s most compelling healthcare markets. We will also gain access to Rongheng’s 400-plus product portfolio, which will make our existing offering even more robust.”